NeutraHealth says that it has ended partial offer discussions with India-based Elder Pharmaceuticals.
Management does not believe that Elder gaining majority control would be in the best interests of the minority shareholders.
Shares in NeutraHealth fell 0.375p to 4.125p each, which values the natural pharmaceuticals supplier at £7.26m. The share price is still higher than before the partial bid discussions were revealed.
NeutraHealth will report its 2008 results on 23 March 2009.
© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds